May 13, 2024 — Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
-
-
May 13, 2024 — Even though mortality and hospitalization rates have improved, the quality of life for those living with hypertrophic cardiomyopathy (HCM) can be compromised with limiting symptoms such ...
-
April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study observing the benefits of scalable, accessible digital health tools for a ...
-
April 18, 2024 — New evidence-based research calls into question the conventional three-month blanking period immediately after atrial fibrillation (AF) ablation, when early occurrences of AF are ...
May 14, 2024 — One of the most common genetic heart diseases worldwide, hypertrophic cardiomyopathy (HCM) causes the ...
May 14, 2024
May 14, 2024 — An ambitious, nationwide clinical trial led by UVA Health’s Karen Johnston, MD, has provided doctors with ...
May 14, 2024
May 13, 2024 — Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms ...
May 13, 2024
May 13, 2024 — Even though mortality and hospitalization rates have improved, the quality of life for those living with ...
May 13, 2024
May 10, 2024 — Scientists from Immanuel Kant Baltic Federal University proved that Raman spectroscopy, a method by which ...
May 10, 2024
May 8, 2024 — In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the ...
May 08, 2024
May 8, 2024 — Ultrasound could one day complement or even replace drugs to treat diseases. Bioelectronic medicine ...
May 08, 2024
May 7, 2024 — Medtronic announced the release of important clinical outcomes in two leading transcatheter valve ...
May 07, 2024
May 2, 2024 — Reprieve Cardiovascular, Inc. (‘Reprieve’), a development stage company focused on pioneering an ...
May 02, 2024
May 2, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular ...
May 02, 2024
May 1, 2024 — A study in more than 3,000 US counties, with 315 million residents, has suggested that air pollution is ...
May 01, 2024
May 1, 2024 —In this 3-stage study, 3 cohorts were used for diagnostic performance, and prognostic performance ...
May 01, 2024
April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College ...
April 30, 2024
April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart ...
April 30, 2024
April 29, 2024 — Women with heart disease are less often treated with cholesterol-lowering drugs than men, according to ...
April 29, 2024© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now